Hunt 2008.

Methods	Randomised trial
Participants	463 hypertensive patients (intervention 230; control 233). 9 community‐based primary care clinics from primary care research network Oregon, USA Year of study: Not stated.
Interventions	Intervention comprised physician‐pharmacist collaboration following hypertension management guidelines. Pharmacists reviewed medication, lifestyle habits, assessed vital signs and reactions, provided education, identification of barriers to adherence and provided a regimen. Average of 7.2 total visits between pharmacists and physicians
Outcomes	Systolic and diastolic blood pressure (BP) at 12 months SF‐36 (physical functioning) at 12 months BP in range
Notes	Funding source: Boehringer Ingelheim funded the cost of the educational mailings and the conduction of the study. Conflict of interest: All data collection, analysis, and reporting were conducted by the study investigators and the Providence research staff. The investigators report no other conflict of interest.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Using a computer‐generated random sequence
Allocation concealment (selection bias)	Low risk	Using a computer‐generated random sequence
Blinding of participants and personnel (performance bias) All Outcomes/Outcome 1	High risk	Participant blinding was not possible. Knowledge of allocation may have influenced behaviour.
Blinding of outcome assessment (detection bias) All Outcomes/Outcome 1	Low risk	Blood pressure was assessed by registered nurses blinded to participants’ randomisation allocation
Incomplete outcome data (attrition bias) All outcomes	High risk	Between group attrition < 10% but overall attrition rate >40%
Selective reporting (reporting bias)	Low risk	All outcomes reported
Other bias	Low risk	None identified